Evicenter
Xtandi (enzalutamide) in Castration-resistant prostate cancer
Manufacturer
Astellas Pharma US, Inc.; Pfizer Inc.
Prescribing information
Xtandi (opens in a new tab)
Questions
20
Last updated

All questions

Safety: Xtandi (enzalutamide) in castration-resistant prostate cancer

4 questions · 1 source

Side effects

What are the side effects of Xtandi in nonmetastatic CRPC (PROSPER)?

Applies to Non-metastatic castration-resistant prostate cancer (PROSPER)

Note: Each table row lists XTANDI Grade 1-4, XTANDI Grade 3-4, comparator Grade 1-4, and comparator Grade 3-4 percentages, in that order, as in the table header. The comparator is placebo.

What are the side effects of Xtandi in chemotherapy-naive metastatic CRPC (PREVAIL)?

Applies to Chemotherapy-naive metastatic castration-resistant prostate cancer (PREVAIL)

“Table 2. Adverse Reactions in PREVAIL XTANDI (N = 871) Placebo (N = 844) Grade 1-41 (%) Grade 3-4 (%) Grade 1-4 (%) Grade 3-4 (%) General Disorders Asthenic Conditions2 47 3.4 33 2.8 Peripheral Edema 12 0.2 8 0.4 Musculoskeletal and Connective Tissue Disorders Back Pain 29 2 22 3 Arthralgia 21 1.6 16 1.1 Gastrointestinal Disorders Constipation 23 0.7 17 0.4 Diarrhea 17 0.3 14 0.4 Vascular Disorders Hot Flush 18 0.1 8 0 Hypertension 14 7 4.1 2.3 Nervous System Disorders Dizziness3 11 0.3 7 0 Headache 11 0.2 7 0.4 Dysgeusia 8 0.1 3.7 0 Mental Impairment Disorders4 6 0 1.3 0.1 Restless Legs Syndrome 2.1 0.1 0.4 0 Respiratory Disorders Dyspnea5 11 0.6 8 0.6 Infections and Infestations Upper Respiratory Tract Infection6 16 0 11 0 Lower Respiratory Tract And Lung Infection7 8 1.5 4.7 1.1 Psychiatric Disorders Insomnia 8 0.1 6 0 Renal and Urinary Disorders Hematuria 9 1.3 6 1.3 Injury, Poisoning and Procedural Complications Fall 13 1.6 5 0.7 Non-Pathological Fracture 9 2.1 3 1.1 Metabolism and Nutrition Disorders Decreased Appetite 19 0.3 16 0.7 Investigations Weight Decreased 12 0.8 8 0.2 Reproductive System and Breast Disorders Gynecomastia 3.4 0 1.4 0 1. CTCAE v 4. 2. Includes asthenia and fatigue. 3. Includes dizziness and vertigo. 4. Includes amnesia, memory impairment, cognitive disorder, and disturbance in attention. 5. Includes dyspnea, exertional dyspnea, and dyspnea at rest. 6. Includes nasopharyngitis, upper respiratory tract infection, sinusitis, rhinitis, pharyngitis, and laryngitis. 7. Includes pneumonia, lower respiratory tract infection, bronchitis, and lung infection.” (opens the source at this quote in a new tab)

Note: Each table row lists XTANDI Grade 1-4, XTANDI Grade 3-4, comparator Grade 1-4, and comparator Grade 3-4 percentages, in that order, as in the table header. The comparator is placebo.

What are the side effects of Xtandi after docetaxel in metastatic CRPC (AFFIRM)?

Applies to Metastatic castration-resistant prostate cancer after docetaxel-based chemotherapy (AFFIRM)

Note: Each table row lists XTANDI Grade 1-4, XTANDI Grade 3-4, comparator Grade 1-4, and comparator Grade 3-4 percentages, in that order, as in the table header. The comparator is placebo. Table 1 continues from page 5 to page 6 of the Prescribing Information, where its header repeats.

Xtandi vs bicalutamide: how did side effects compare in TERRAIN?

Applies to Chemotherapy-naive metastatic castration-resistant prostate cancer, compared with bicalutamide (TERRAIN)

Note: Each table row lists XTANDI Grade 1-4, XTANDI Grade 3-4, comparator Grade 1-4, and comparator Grade 3-4 percentages, in that order, as in the table header. The comparator is bicalutamide.